ENDRA Life Sciences (NDRA) Operating Leases (2019 - 2021)
Historic Operating Leases for ENDRA Life Sciences (NDRA) over the last 3 years, with Q3 2021 value amounting to $680526.0.
- ENDRA Life Sciences' Operating Leases rose 8689.97% to $680526.0 in Q3 2021 from the same period last year, while for Sep 2021 it was $680526.0, marking a year-over-year increase of 8689.97%. This contributed to the annual value of $348388.0 for FY2020, which is 1482.06% down from last year.
- Per ENDRA Life Sciences' latest filing, its Operating Leases stood at $680526.0 for Q3 2021, which was up 8689.97% from $709385.0 recorded in Q2 2021.
- ENDRA Life Sciences' 5-year Operating Leases high stood at $709385.0 for Q2 2021, and its period low was $331520.0 during Q1 2021.
- Over the past 3 years, ENDRA Life Sciences' median Operating Leases value was $401708.5 (recorded in 2019), while the average stood at $457694.9.
- Over the last 5 years, ENDRA Life Sciences' Operating Leases had its largest YoY gain of 8689.97% in 2021, and its largest YoY loss of 1594.58% in 2021.
- ENDRA Life Sciences' Operating Leases (Quarter) stood at $409005.0 in 2019, then fell by 14.82% to $348388.0 in 2020, then skyrocketed by 95.34% to $680526.0 in 2021.
- Its Operating Leases stands at $680526.0 for Q3 2021, versus $709385.0 for Q2 2021 and $331520.0 for Q1 2021.